Martin Olovsson

Martin Olovsson has a broad experience from portfolio & product strategy in the pharmaceutical industry. Currently, Martin is the CEO and co-founder of AstraZeneca’s spin-out company OnDosis, developing a 1st in category Dosage Manager, a connected handheld device platform for individualized dosing of oral medicines. From 1992-2017 he has held several international senior positions within AstraZeneca, for example, President of the Nordic/Baltic and Global Vice President for the Inhaled Respiratory franchise. He is also board member of Aqilion, WntResearch AB and Scientific Med AB.